One-carbon Therapeutics offers scientific solutions for treatment against MTHFD1/2 cancer proteins and related targets.
One-carbon Therapeutics has raised $16.2M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2025.
One-carbon Therapeutics is headquartered in Stockholm, Sweden.
One-carbon Therapeutics offers scientific solutions for treatment against MTHFD1/2 cancer proteins and related targets.
One-carbon Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"One-carbon Therapeutics — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/one-carbon-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). One-carbon Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/one-carbon-therapeutics
{{cite web |title=One-carbon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/one-carbon-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated